Results 91 to 100 of about 19,211 (198)

Cytochrome P450 2C9-CYP2C9 [PDF]

Pharmacogenetics and Genomics, 2010
Derek, Van Booven, Sharon, Marsh, Howard, McLeod, Michelle Whirl, Carrillo, Katrin, Sangkuhl, Teri E, Klein, Russ B, Altman   +6 more
openaire   +2 more sources

Frequencies of CYP2C9 polymorphisms in a Syrian cohort

BMC Genomics
The cytochrome P450 family 2 subfamily C member 9 (CYP2C9) exhibits extensive genetic variability that may influence the metabolism of approximately 16-20% of all drugs. Understanding the frequency and functional impact of the CYP2C9 variants is crucial for the implementation of pharmacogenetics.
Weam Aldiban, Majd N. Aljamali, Lama A. Youssef   +2 more
openaire   +3 more sources

The Relationship Between Warfarin Resistance and CYP2C9*2 and CYP2C9*3 Variatıons

Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2021
Deniz Kıraç, Aysun Erdem Yaman, Tansu Doran, Elif Çiğdem Altunok   +3 more
openaire   +1 more source

The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients

Frontiers in Pharmacology
BackgroundLimited data are available on factors that affect warfarin dose requirement in Saudi patients. Saudis are among the underrepresented ethnic groups in warfarin pharmacogenetics research.
Salha Jokhab, Maha M. AlRasheed, Dana Bakheet, Abdulkareem AlMomen, Nouf AlAboud, Farhad Kamali   +5 more
doaj   +1 more source

GENETIC POLYMORPHISM OF CYTOCHROMES P450 2C9 AND 2C19 IN SLOVENIAN POPULATION

Zdravniški Vestnik, 2003
Background. Cytochrome P450 2C9 (CYP2C9) and 2C19 (CYP2C19) participate in metabolism of many clinically important drugs. Genetic polymorphisms of the CYP2C9 and CYP2C19 genes are described which may affect drug treatment.
Darja Herman, Vita Dolžan, Katja Breskvar   +2 more
doaj  

Polymorphism of the CYP2C9 and VKORC1 genes: a comment [PDF]

Jornal Vascular Brasileiro, 2021
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit, Christiane de Fátima Colet   +2 more
openaire   +4 more sources

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment

Pharmacogenomics and Personalized Medicine, 2018
Carlos Eduardo Silvado,1 Vera Cristina Terra,1 Carlos Alexandre Twardowschy2 1Comprehensive Epilepsy Program, Hospital de Clinicas, Federal University of Parana (UFPR), Curitiba, Brazil; 2Department of Neurology, Catholic University of Parana (PUCPR ...
Silvado CE, Terra VC, Twardowschy CA
doaj  

CYP2C9 Inducer [PDF]

, 2020
openaire   +1 more source

CYP2C9 Substrate [PDF]

, 2020
openaire   +1 more source

The association of ABCB1, CYP2C19 and CYP2C9 combined activity with clopidogrel resistance in patients with recurrent ischemic stroke. [PDF]

Pharmacogenomics J
Deiman B, Hermans M, de Rijk M, Bras A, Scharnhorst V.   +4 more
europepmc   +1 more source